Skip to main content
Testing version — LOERadar is in active testing. Features and data may change.
LOERadar
LOE
Radar
Hub
News
Changes
Search
Log in
Get Started
OHTUVAYRE (ENSIFENTRINE) | LOERadar
Viewing data from:
Latest
2026-07-01
2026-06-01
2026-05-01
2026-04-01
2026-03-28
2026-02-17
2026-02-10
2025-12-14
2025-02-26
2025-01-25
2024-11-08
2023-07-23
2023-06-15
2023-05-13
2023-01-26
2022-11-22
2022-10-28
2022-09-29
2022-07-09
2022-06-29
2022-04-08
2022-03-09
2021-12-28
2021-05-05
2021-03-12
2020-12-22
2020-11-12
2019-12-14
2019-09-15
OHTUVAYRE
NDA
Get alerts
ENSIFENTRINE | N217389 | MERCK SHARP AND DOHME LLC
1 strength
5 unique patents
1 unique exclusivity
Patents
SEC Intel
Revenue
PTAB
Reexams
Litigation
Petitions
Trials
DMF
Approvals
Label
Products
Patent Timeline
5 unique patents, 1 exclusivity by expiration date
Active (5)
Today
Exclusivity
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
2043
2044
2045
Today
9062047
Aug. 21, 2031
9956171
Sep. 15, 2035
10945950
Sep. 15, 2035
12251384
Jun. 25, 2044
12409180
Feb. 20, 2043
NCE
Jun. 26, 2029
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
No ANDA patent litigation cases (NOS 835) matched from PACER
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (1)
#001 — 3MG/2.5ML
RLD
5 patents
1 exclusivity
▴
SUSPENSION;INHALATION | Approved: Jun 26, 2024
Patents (5)
Patent #
Expiration
PED
Drug Substance
Drug Product
Use Code
Delist
9062047
Aug 21, 2031
—
Yes
—
U-3962
FOR THE MAINTENANCE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN ADULT PATIENTS
—
9956171
Sep 15, 2035
—
—
Yes
U-3962
FOR THE MAINTENANCE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN ADULT PATIENTS
—
10945950
Sep 15, 2035
—
—
Yes
—
—
12251384
Jun 25, 2044
—
—
Yes
—
—
12409180
Feb 20, 2043
—
—
Yes
—
—
Exclusivities (1)
Code
Date
Status
NCE
Jun 26, 2029
Active